Acknowledging the kind of traction gained by this market, Industry data Analytics recently published a study report asserts the global Medical Marijuana Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 20.9% during the review period (2022 to 2027).
The market is experiencing growth due to rising awareness regarding various medical applications such as pain management, appetite enhancement, and reducing eye pressure.Medical marijuana is mainly classified into two types, namely Cannabis Sativa and Cannabis indica, which originate from the countries of the Western hemisphere and Central and South Asian regions respectively. The growing number of countries legalizing the use of medical marijuana in various parts of this world is one of the key factors driving the usage rate of cannabis in therapeutic applications.
Based on application, the pain management segment is expected to dominate this market, owing to increasing incidence of pain related conditions, such as migraine, cancer pain and others. For instance, in previous year, the Centers for Disease Control and Prevention (CDC) reported that an estimated 50 million Americans, or just over 20%, have some form of chronic pain. People suffering from chronic pain tend to adopt high dosage of painkiller for instant relief. Though, growing intake of painkillers may result in multiple side effects. Hence, the medical community initiated the usage of cannabis as an alternative for pain management, thereby augmenting the market growth.
Industry Developments:
21 Dec 2020: Tilray Inc. and Aphria Inc. have agreed to an all-stock merger, which would create the world's largest cannabis company by sales. The merger will result in a company holding a whopping 17% share of the Canadian cannabis market and is a strategic move that will likely provide each company security about their future in a post-pandemic world. The combined company is reported to have an implied pro forma equity value of $3.9 bn.
The Medical Marijuana Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market includes CanniMed Therapeutics, Scotts Miracle-Gro, Canopy Growth Corporation, Aurora Cannabis, Aphria Inc., CannTrust Holdings, GW Pharmaceuticals, MedReleaf Corp, ABcann Medicinals, Inc., Emerald Health Therapeutics, Green Relief Inc., The Cronos Group, Medical Marijuana, Inc., and others.
Medical Marijuana Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application it is segmented into
The market in North America is poised to hold maximum market share across the forecast period 2022-2027. The region held lion’s share owing to the U.S. being the most prominent country for cannabis market. Furthermore, growing number of legalizations pertaining to the usage of cannabis plant for medical as well as recreational purposes in more than 30 states of the U.S. have significantly contributed to the growing revenue of the region.
Moreover, Europe is the second largest region cultivating cannabis for medical conditions and adult use. The marijuana industry in Europe is expected to witness lucrative growth across the forecast period due to increasing legalizations coupled with rising investments by several major companies. Top key players operating in the United States are focusing on geographical expansion strategies to penetrate the market in Europe and thereby boosting regional growth.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 20.9% during the review period (2022 to 2027). |
By Type |
|
By Application |
|
By Companies | CanniMed Therapeutics, Scotts Miracle-Gro, Canopy Growth Corporation, Aurora Cannabis, Aphria Inc., CannTrust Holdings, GW Pharmaceuticals, MedReleaf Corp, ABcann Medicinals, Inc., Emerald Health Therapeutics, Green Relief Inc., The Cronos Group, Medical Marijuana, Inc., Others |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 95 |
Customization Available | Yes, the report can be customized as per your needs |
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
What is the study period of this market?
The Medical Marijuana Market is studied from 2017 - 2027.
What is the growth rate of Medical Marijuana Market?
The Medical Marijuana Market is growing at a CAGR of 20.9% over the next 5 years.
Who are the leading key players in Medical Marijuana Market?
CanniMed Therapeutics, Scotts Miracle-Gro, Canopy Growth Corporation, Aurora Cannabis, Aphria Inc., CannTrust Holdings, GW Pharmaceuticals, MedReleaf Corp, ABcann Medicinals, Inc., Emerald Health Therapeutics, Green Relief Inc., The Cronos Group, Medical Marijuana, Inc., Others
What regions regions does this Medical Marijuana Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Medical Marijuana Market?
Dried Flower, Oils + Concentrates, Softgel Capsules
What are the significant Applications of Medical Marijuana Market?
Muscle Spasms, Nausea (from cancer chemotherapy), Chronic Illness (HIV/Nerve Pain), Seizure Disorders, Crohn's Disease
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.